← FDA Drug Approvals (Drugs@FDA)
DASATINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2025-11-06
Drug application
- FDA Application #
ANDA216261- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DASATINIB
- Generic name
- DASATINIB
- Active ingredients
- DASATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- Manufacturer
- Alembic Pharmaceuticals Limited
- First approval
- 2025-11-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown